| Poxviruses and immune evasion BT Seet, JB Johnston, CR Brunetti, JW Barrett, H Everett, C Cameron, ... Annual review of immunology 21 (1), 377-423, 2003 | 769 | 2003 |
| The complete DNA sequence of myxoma virus C Cameron, S Hota-Mitchell, L Chen, J Barrett, JX Cao, C Macaulay, ... Virology 264 (2), 298-318, 1999 | 305 | 1999 |
| A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection JB Johnston, JW Barrett, SH Nazarian, M Goodwin, D Ricuttio, G Wang, ... Immunity 23 (6), 587-598, 2005 | 268 | 2005 |
| Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas S Papillon-Cavanagh, C Lu, T Gayden, LG Mikael, D Bechet, ... Nature genetics 49 (2), 180-185, 2017 | 233 | 2017 |
| Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor G Wang, JW Barrett, M Stanford, SJ Werden, JB Johnston, X Gao, M Sun, ... Proceedings of the National Academy of Sciences 103 (12), 4640-4645, 2006 | 230 | 2006 |
| Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier F Wang, Y Ma, JW Barrett, X Gao, J Loh, E Barton, HW Virgin IV, ... Nature immunology 5 (12), 1266-1274, 2004 | 227 | 2004 |
| Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action V Van Berkel, J Barrett, HL Tiffany, DH Fremont, PM Murphy, G McFadden, ... Journal of virology 74 (15), 6741-6747, 2000 | 223 | 2000 |
| Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas X Lun, W Yang, T Alain, ZQ Shi, H Muzik, JW Barrett, G McFadden, J Bell, ... Cancer research 65 (21), 9982-9990, 2005 | 194 | 2005 |
| Use of chemokine receptors by poxviruses AS Lalani, J Masters, W Zeng, J Barrett, R Pannu, H Everett, CW Arendt, ... Science 286 (5446), 1968-1971, 1999 | 194 | 1999 |
| Immunomodulation by viruses: the myxoma virus story P Nash, J Barrett, JX Cao, S HotaMitchell, AS Lalani, H Everett, XM Xu, ... Immunological reviews 168 (1), 103-120, 1999 | 172 | 1999 |
| Modulating chemokines: more lessons from viruses AS Lalani, JW Barrett, G McFadden Immunology today 21 (2), 100-106, 2000 | 167 | 2000 |
| The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4 M Mansouri, E Bartee, K Gouveia, BT Hovey Nerenberg, J Barrett, ... Journal of virology 77 (2), 1427-1440, 2003 | 156 | 2003 |
| Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV-counterparts that has implications for immunotherapy SF Gameiro, F Ghasemi, JW Barrett, J Koropatnick, AC Nichols, ... Oncoimmunology 7 (10), e1498439, 2018 | 136 | 2018 |
| Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system AC Nichols, LE Lowes, CCT Szeto, J Basmaji, S Dhaliwal, C Chapeskie, ... Head & neck 34 (10), 1440-1444, 2012 | 129 | 2012 |
| Fourpool modeling of proton exchange processes in biological systems in the presence of MRI–paramagnetic chemical exchange saturation transfer (PARACEST) agents AX Li, RHE Hudson, JW Barrett, CK Jones, SH Pasternak, R Bartha Magnetic Resonance in Medicine: An Official Journal of the International …, 2008 | 125 | 2008 |
| Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin XQ Lun, H Zhou, T Alain, B Sun, L Wang, JW Barrett, MM Stanford, ... Cancer research 67 (18), 8818-8827, 2007 | 123 | 2007 |
| The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population AC Nichols, DA Palma, SS Dhaliwal, S Tan, J Theuer, W Chow, ... Current oncology 20 (4), 212-219, 2013 | 118 | 2013 |
| RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages F Wang, X Gao, JW Barrett, Q Shao, E Bartee, MR Mohamed, M Rahman, ... PLoS pathogens 4 (7), e1000099, 2008 | 117 | 2008 |
| Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo CM Cameron, JW Barrett, L Liu, AR Lucas, G McFadden Journal of virology 79 (10), 6052-6067, 2005 | 108 | 2005 |
| Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo CM Cameron, JW Barrett, M Mann, A Lucas, G McFadden Virology 337 (1), 55-67, 2005 | 107 | 2005 |
Anthony C. Nichols, MD FRCSCProfessor, Department of Otolaryngology - Head and Neck Surgery, Western University在 lhsc.on.ca 的电子邮件经过验证
